Citadel Advisors
LABD icon

Citadel Advisors’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Citadel Advisors’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.36M Buy
144,560
+54,860
+61% +$1.04M ﹤0.01% 5744
2025
Q4 		$1.89M Buy
89,700
+73,860
+466% +$2M ﹤0.01% 6033
2025
Q3 		$641K Sell
15,840
-4,270
-21% -$247K ﹤0.01% 8535
2025
Q2 		$1.5M Buy
20,110
+10,910
+119% +$965K ﹤0.01% 6249
2025
Q1 		$868K Sell
9,200
-1,090
-11% -$79.8K ﹤0.01% 7279
2024
Q4 		$746K Sell
10,290
-3,110
-23% -$190K ﹤0.01% 7659
2024
Q3 		$783K Buy
13,400
+1,730
+15% +$105K ﹤0.01% 7339
2024
Q2 		$855K Sell
11,670
-9,990
-46% -$843K ﹤0.01% 6910
2024
Q1 		$1.58M Buy
21,660
+350
+2% +$29.2K ﹤0.01% 5989
2023
Q4 		$2.06M Buy
21,310
+13,280
+165% +$2.58M ﹤0.01% 5294
2023
Q3 		$1.65M Buy
8,030
+5,430
+209% +$882K ﹤0.01% 5560
2023
Q2 		$374K Sell
2,600
-420
-14% -$62.7K ﹤0.01% 8553
2023
Q1 		$622K Sell
3,020
-4,770
-61% -$810K ﹤0.01% 7855
2022
Q4 		$1.34M Sell
7,790
-7,190
-48% -$1.47M ﹤0.01% 6254
2022
Q3 		$3.59M Buy
14,980
+3,360
+29% +$781K ﹤0.01% 4456
2022
Q2 		$4.53M Buy
11,620
+3,690
+47% +$1.85M ﹤0.01% 3994
2022
Q1 		$2.78M Buy
7,930
+1,141
+17% +$447K ﹤0.01% 5368
2021
Q4 		$1.75M Buy
6,789
+256
+4% +$58.9K ﹤0.01% 6561
2021
Q3 		$1.39M Buy
6,533
+933
+17% +$198K ﹤0.01% 7294
2021
Q2 		$1.08M Sell
5,600
-1,130
-17% -$253K ﹤0.01% 8173
2021
Q1 		$1.46M Sell
6,730
-722
-10% -$140K ﹤0.01% 7167
2020
Q4 		$1.88M Buy
7,452
+5,482
+278% +$2.09M ﹤0.01% 5464
2020
Q3 		$1.18M Buy
1,970
+1,430
+265% +$923K ﹤0.01% 5736
2020
Q2 		$375K Buy
540
+167
+45% +$210K ﹤0.01% 7548
2020
Q1 		$1.05M Sell
373
-13
-3% -$37.1K ﹤0.01% 5253
2019
Q4 		$952K Buy
386
+102
+36% +$362K ﹤0.01% 5673
2019
Q3 		$1.44M Sell
284
-275
-49% -$1.13M ﹤0.01% 4993
2019
Q2 		$2.01M Buy
559
+188
+51% +$792K ﹤0.01% 4498
2019
Q1 		$1.36M Buy
371
+132
+55% +$639K ﹤0.01% 5067
2018
Q4 		$2.04M Buy
239
+89
+59% +$653K ﹤0.01% 4115
2018
Q3 		$730K Buy
150
+74
+97% +$357K ﹤0.01% 6085
2018
Q2 		$391K Buy
+76
New +$461K ﹤0.01% 6772
2018
Q1 		– Sell
-19
Closed -$175K – 8548
2017
Q4 		$175K Sell
19
-2
-10% -$19.9K ﹤0.01% 7196
2017
Q3 		$195K Buy
+21
New +$253K ﹤0.01% 6713

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Citadel Advisors's LABD Position: Q1 2026 in Review

Citadel Advisors reduced its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 32% in Q1 2026, selling an estimated $833K and leaving 91,781 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #6715.

Citadel Advisors first reported a position in LABD in Q4 2015 and has held it in 33 quarters since. The position peaked at $5.55M in Q3 2024. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • Citadel Advisors held 91,781 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $1.5M as of Q1 2026.
  • Citadel Advisors sold 43,998 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $833K.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6715 holding.
  • Citadel Advisors first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2015 and has held it in 33 quarters since.
  • Citadel Advisors's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $5.55M in Q3 2024.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.